The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Healthy Life
-
- Employees
1968
At Healthylife, we’re making good health even easier and more accessible. Healthylife was built alongside health experts to help ditch the complexity around health and make living healthier, easier.
Product
Dithiazide Hydrochlorothiazide (25mg) 100 Tablets
PharmEvo Private Limited
Karachi Division, Pakistan
1001-5000 Employees
1999
We are proud of each step of our transformational journey, and our mission to provide quality and innovative healthcare solutions has made us among the top 20 Pharmaceutical companies in Pakistan. The PharmEvo family is committed to improving lives by developing, manufacturing and marketing high-quality products. Our mission is to provide tech-driven and innovative healthcare solutions through cause-based marketing and become a leading socially responsible global company.
Product
Telsarta D(Telmisartan + Hydrochlorothiazide )
Almatica Pharma
Morristown, United States
251-500 Employees
-
Almatica is focused on the development, acquisition and commercialization of branded prescription products. Almatica is actively pursuing the expansion of its US product portfolio through the development of its own product pipeline and through the in-licensing and acquisition of products that are either marketed or in late-stage development. Almatica is a privately held, US pharmaceutical company focused on the development, acquisition and commercialization of brand named pharmaceutical products. Almatica is actively pursuing the expansion of its US product portfolio through the development of its own product pipeline and through the in-licensing and acquisition of products that are either marketed in the US or are in late stage development. Lisa founded Almatica in 2009 and serves as the CEO. Under Lisa’s leadership, Almatica is actively pursuing the expansion of its US product portfolio through the development of its own product pipeline and through the in-licensing and acquisition of products that are either marketed in the US or are in late-stage development. Almatica is actively looking to expand of its US product portfolio through the in-licensing and acquisition of products (both in-market or in late stage development). Join Almatica and find yourself among our team of employees from all around the US, bringing combined knowledge and expertise to our mission.
Product
Zestoretic® (lisinopril and hydrochlorothiazide)
Pope Electrical
Perth, Australia
11-50 Employees
1996
Pope Electrical are a Western Australian based company established in 1996.
Service
Hydrochlorothiazide 12.5 Mg Generic >> Generic Pills Online
GNH India Pharmaceuticals Limited
Mumbai, India
11-50 Employees
-
We are one of the Pioneers in Comparator drug supplies from India ! Our goal is to source, distribute and deliver pharmaceutical products to everyone who needs them most, and all without any of the unforeseen delays that you simply cannot afford. We are impressed by the efficiency and the high quality standard of your company. GNHIndia Pharmaceuticals has been representing India since since 2011. GNH India is a Global Pharmaceutical Distributor with over 203,000 products lines covering Original brands and True Generic. This summary is designed to provide you an overview and help you in managing the company’s finances. Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders. At GNH India, we take pride in being a leading pharmaceuticals distributor and believe nothing should stand in the way of what people truly need.
Product
Zestoretic - Lisinopril & Hydrochlorothiazide
EliteSynth Laboratories
Navi Mumbai, India
11-50 Employees
2019
Elitesynth is a custom synthesis and analytical laboratory. Established in 2019 and we are based in India. To be a leading service provider in India and a significant global player by providing innovative and affordable solutions. To provide quality and affordable services to the pharmaceutical industry under one roof and ensure total customer satisfaction.
Product
Hydrochlorothiazide Impurity C – Hydrochlorothiazide Dimer
Padagis
United States
251-500 Employees
-
Padagis LLC 3940 Quebec Ave N Minneapolis, MN 55427. Padagis LLC 1251 Lincoln Rd Allegan, MI 49010. Padagis LLC 301 Grove Reserve Parkway Piedmont, SC 29673. Improve the well-being of patients and consumers by providing high quality, affordable, specialized healthcare products. Extended topicals is a category of products that include prescription creams, ointments, suspensions, gels, foams, sprays, patches, nasal, and suppositories. Paragraph IV products are a specialty of Padagis, where we focus on manufacturing items that involve challenging branded pharmaceutical patents. The ability to build successful partnerships is a major reason Padagis is the generic pharmaceutical leader in extended topicals.
Product
Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg
Teva Pharmaceuticals
North Wales, United States
10001+ Employees
1900
Our goal is to provide innovative treatments and quality generic and biosimilar medicines for millions of people. As a leading provider of generic drugs, Teva Pharmaceuticals understands the importance of making safe, quality medications accessible - and affordable. In the United States, Teva markets over 500 generic prescription products in more than 1,500 dosage strengths, packaging sizes and forms, including oral solid dosage forms, injectable products, inhaled products, transdermal patches, and topical formulations. Additionally, Teva employs nearly 6,100 employees in the United States and operates in 11 states and Puerto Rico. Learn more about our history and how we have grown to be a leading provider of generic drugs. Choosing Teva Generics is choosing to enjoy the benefits Teva can provide. Clinical trials are essential for the development of health care products and it is increasingly recognised there is a need for increased diversity in trial participation. We strive to make innovative and accessible medicines to improve patient health.
Product
Triamterene and Hydrochlorothiazide Tablets, USP
Rising Pharmaceuticals
East Brunswick Township, United States
51-100 Employees
-
Our products are manufactured in state-of-the-art GMP facilities using quality assurance techniques that meet regulatory standards. We are focused on the development of Abbreviated New Drug Application (ANDA)-based generic products through our global network of development and manufacturing partners and have a robust emerging pipeline of pharmaceutical products. Through our close partnerships throughout the United States, we ensure the safe and effective delivery of our products to the public. We also market a few legacy OTC products. From our manufacturers, partners and pharmacies to physicians and their patients, our goal is to make life better for everyone we impact. We believe in understanding the specific needs of our patients so we can provide them with the best treatments and educational materials possible. Working together with our partners, we strive to offer greater access to affordable medication that you can trust. Rising Pharma Holdings Inc emerges as a privately held company dedicated to selling generic prescription products and over-the-counter pharmaceutical products under the Rising label to leading wholesalers, chain drug stores, distributors and mass merchandisers.
Product
Hydrochlorothiazide Caps / 12.5 mg / 1000 Count – Rising Pharmaceuticals
CLICKCHEM RESEARCH LLP
Ankleshwar, India
1-10 Employees
2021
We Are Supplier And Manufacturer Of Impurity Standards. Our Vision Is To Become A Globally Recognized And Trusted Name In The Pharmaceutical Industry By Consistently Delivering High-Quality And Innovative Solutions To Our Customers. We Are Offering Prompt And Efficient Communication, Provide Customized Solutions To Meet Clients’ Needs, And Address Any Concerns Or Issues Promptly. Clickchem research LLP started in 2021, we are leading manufacturing and supplier of pharmaceutical materials like API Intermediates, impurities and catalyst, We provide services regarding purification, isolation, & characterisation of unknown molecules and develop the R&D route to synthesis the target molecules to our customers on contract basis for critical molecules. We Meet The Desired Product Standard And Achieve Customer Satisfaction And Loyalty Through Supply In Time At Economically Competitive Prices. Established In 2020, Clickchem Research LLP Is A Market-Leading Manufacturer And Supplier Of Pharmaceutical Materials Such As API Intermediates, Impurities, And Catalysts. We Offer Purification, Isolation, And Characterization Services For Unidentified Molecules As Well As Developing R&D Routes To Synthesize Critical Molecules For Our Clients. As A Manufacturer And Supplier Of Pharmaceutical Materials, Clickchem Research LLP Needs To Ensure That The Products They Offer Meet The Highest Standards Of Quality.
Product
Hydrochlorothiazide EP Impurity C - Clickchem Research LLP
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about your company results for Hydrochlorothiazide
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 1094 |
| Amount of suitable service providers | 1093 |
| Average amount of employees | 51-100 |
| Oldest suiting company | 1964 |
| Youngest suiting company | 2015 |
20%
40%
60%
80%
Hydrochlorothiazide is a medication classified under the category of thiazide diuretics, commonly referred to as water pills. It operates by inhibiting the kidneys' ability to retain sodium, facilitating the excretion of excess salt and water from the body. This mechanism significantly reduces the volume of fluid flowing through the blood vessels, which in turn lowers blood pressure and decreases the heart's workload. Beyond its primary application in managing hypertension, hydrochlorothiazide is also prescribed for conditions such as edema associated with heart failure, chronic kidney disease, and certain liver disorders where fluid retention presents a significant problem. Its efficacy in reducing the risk of stroke and heart attacks by controlling high blood pressure is well-documented, making it a cornerstone in cardiovascular disease prevention strategies. Additionally, by mitigating fluid retention, it aids in alleviating the physical discomfort and potential complications arising from excess fluid accumulation. However, it's crucial for patients to be aware of potential side effects, including electrolyte imbalances, which may necessitate regular monitoring by a healthcare provider. Through its targeted action on the kidneys and the circulatory system, hydrochlorothiazide plays a pivotal role in the therapeutic management of hypertension and fluid-related disorders, contributing to the improvement of patient outcomes in these areas.
1. Cost-Effectiveness
Hydrochlorothiazide is generally more affordable than many of its alternatives. This cost advantage makes it a preferred choice for long-term treatment, especially for patients managing conditions like hypertension on a tight budget.
2. Lower Side Effect Profile
Compared to other diuretics, Hydrochlorothiazide has a lower incidence of side effects. Its mild action on the kidneys makes it suitable for patients who may be sensitive to stronger diuretics, thus promoting better patient compliance.
3. Versatility in Treatment Applications
This medication is not only effective in controlling high blood pressure but also beneficial in treating edema and certain cases of kidney stones. Its versatility in treating various conditions with a single medication simplifies treatment plans for both patients and healthcare providers.
4. Compatibility with Other Medications
Hydrochlorothiazide can be easily combined with other blood pressure medications to achieve better control over hypertension without significant risk of adverse interactions. This compatibility makes it an essential component of combination therapy, offering a more tailored and effective treatment approach.
1. Regulatory Compliance
Ensure the supplier adheres to international and local regulations, including FDA or EMA guidelines, for the production and distribution of Hydrochlorothiazide.
2. Quality Assurance
Verify that the supplier has robust quality control systems in place, such as Good Manufacturing Practice (GMP) certifications, to guarantee the purity and potency of Hydrochlorothiazide.
3. Supply Chain Reliability
Assess the supplier's ability to provide consistent and timely delivery. A reliable supply chain minimizes the risk of shortages or delays.
4. Cost-effectiveness
While not compromising on quality or compliance, consider the supplier's pricing structure to ensure it aligns with your budgetary constraints.
5. Technical Support
The supplier should offer comprehensive technical and customer support to address any queries or issues that may arise during the supply process.
6. Sustainability Practices
Evaluate the environmental practices of the supplier. Preference should be given to those who demonstrate a commitment to sustainability and eco-friendly manufacturing processes.
Hydrochlorothiazide, a widely used diuretic in the pharmaceutical industry, plays a pivotal role in managing hypertension and edema. In the healthcare sector, businesses specializing in generic medicines often incorporate it into their product lines due to its cost-effectiveness and high demand. This medication is essential for patients requiring long-term treatment, making it a staple in pharmacies and hospitals. In the research and development sphere, companies focus on creating combination drugs that include hydrochlorothiazide to enhance therapeutic efficacy. It's frequently paired with antihypertensive agents to offer a synergistic effect, reducing the risk of cardiovascular diseases. This approach not only improves patient outcomes but also expands the marketability of pharmaceutical products. Furthermore, the veterinary medicine industry utilizes hydrochlorothiazide for treating animals with conditions similar to those in humans, such as heart failure and kidney disease. Its application in this field underscores the versatility of the drug and opens up a secondary market for manufacturers and suppliers, broadening the scope of B2B transactions. Lastly, in the health supplements and nutraceuticals industry, there's a growing interest in exploring hydrochlorothiazide's potential benefits beyond conventional uses. Companies are investigating its role in weight management and fluid retention supplements, aiming to cater to a niche yet significant market segment. This innovative application signifies the drug's expanding utility across various health-related industries.
Hydrochlorothiazide, a well-established diuretic medication used primarily to treat high blood pressure and swelling due to fluid build up, is at Technology Readiness Level (TRL) 9. This classification is attributed to the extensive clinical use and robust data supporting its efficacy and safety across diverse populations. Over decades, hydrochlorothiazide has undergone rigorous clinical trials and regulatory review, leading to its widespread acceptance in the medical community. Its mechanisms of action, involving the inhibition of the kidneys' ability to retain water, have been thoroughly studied, demonstrating a deep understanding of its pharmacokinetics and pharmacodynamics. Furthermore, its integration into treatment guidelines for hypertension and edema underlines its established status in therapeutic protocols. The drug's formulation, dosing, and administration routes have been optimized, ensuring maximum efficacy with minimal side effects, which is a testament to its high TRL. Regulatory agencies globally have approved hydrochlorothiazide for clinical use, further cementing its position at the pinnacle of technology readiness in the pharmaceutical landscape. This culmination of extensive research, clinical validation, and regulatory endorsement precisely encapsulates why hydrochlorothiazide is positioned at TRL 9.
In the Short-Term, advancements in the formulation of hydrochlorothiazide are expected to focus on improving patient compliance and minimizing side effects. Innovations may include the development of extended-release versions to decrease the frequency of dosage and the integration of digital pills technology for better monitoring of adherence to treatment regimes. These enhancements aim to increase the effectiveness of hydrochlorothiazide in managing conditions like hypertension and edema by ensuring more consistent therapeutic levels in the body. The Mid-Term phase is likely to witness significant progress in personalized medicine approaches, leveraging genetic profiling to predict individual responses to hydrochlorothiazide. This period will see the introduction of more sophisticated diagnostic tools and algorithms designed to tailor treatment plans more precisely, enhancing the drug's efficacy and reducing the risk of adverse reactions. Additionally, research into drug interactions will benefit from AI-driven simulations, providing deeper insights into optimizing combination therapies with hydrochlorothiazide for various patient demographics. Looking into the Long-Term, the focus will shift towards completely redefining the role of hydrochlorothiazide through biotechnological advancements. Efforts will be concentrated on developing bioengineered versions of the drug with targeted delivery mechanisms, aiming to directly address the underlying causes of diseases rather than just managing symptoms. This phase might also explore the integration of hydrochlorothiazide into multi-functional drug systems that offer both therapeutic and diagnostic capabilities, potentially revolutionizing the approach to treating cardiovascular and renal diseases.
Some interesting questions that has been asked about the results you have just received for Hydrochlorothiazide
What are related technologies to Hydrochlorothiazide?
Based on our calculations related technologies to Hydrochlorothiazide are Aromatics, Desiccants, Refrigerants, Resins, Green Chemistry
Which industries are mostly working on Hydrochlorothiazide?
The most represented industries which are working in Hydrochlorothiazide are Other, Healthcare, Pharmaceuticals, Retail, Medical
How does ensun find these Hydrochlorothiazide Suppliers?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
